Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05343039 · ClinicalTrials.gov registry record · NA
Technology Enhanced Adolescent Mental Health (TEAM)
A NA study, sponsored by University of Notre Dame.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT05343039 is a NA study that has completed, run by University of Notre Dame. The registered enrollment target is 30 participants.
The verdict
NCT05343039, a NA study, has completed, sponsored by University of Notre Dame.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Adolescent nonsuicidal self-injury (NSSI) and alcohol misuse, alone and especially in combination, portend significant functional impairment in adulthood (e.g., relationship dysfunction, depression, suicidality). Although psychosocial interventions for NSSI and substance use are effective for some, they are also expensive and require highly trained clinicians. Treatment is therefore often unavailable to disadvantaged adolescents and those who live rurally. Thus, lower-cost alternative treatments are needed. We will evaluate the efficacy of noninvasive transcutaneous vagus nerve stimulation (tVNS), an effective treatment for depression, in reducing risk for NSSI and substance misuse among vulnerable adolescents.
Interventions
- DEVICE Non-invasive Transcutaneous Nerve Stimulation (tVNS)
- DEVICE No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2025-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05343039
The ClinicalTrials.gov registry entry for NCT05343039 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Notre Dame, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Non-invasive Transcutaneous Nerve Stimulation (tVNS) is the first listed.
NCT05343039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05343039 about?
NCT05343039 is a clinical study titled "Technology Enhanced Adolescent Mental Health (TEAM)". Adolescent nonsuicidal self-injury (NSSI) and alcohol misuse, alone and especially in combination, portend significant functional impairment in adulthood (e.g., relationship dysfunction, depression, suicidality). Although psychosocial interventions for NSSI and substance use are effective for some, ...
What is the current status of trial NCT05343039?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2022-09-06. Estimated completion is 2025-01-15.
What interventions are being tested in trial NCT05343039?
The interventions under investigation include: Non-invasive Transcutaneous Nerve Stimulation (tVNS) (DEVICE), No Intervention (DEVICE).
Who is sponsoring clinical trial NCT05343039?
This trial is sponsored by University of Notre Dame, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.